Sucampo Pharmaceuticals

Sucampo Pharmaceuticals

Employees:
140
Market Cap:
$441.62 million
Revenue:
$230 million
5 Year Trend:
33.2%
Net Income:
$18.49 million
NASDAQ:
SCMP

Sucampo Pharmaceuticals, Inc. is a public, American biopharmaceutical company focused on medical applications of a class of ion channel modulators called prostones. Sucampo has two marketed products, Amitiza and Rescula. Wikipedia

Sucampo Pharmaceuticals

Sucampo Pharmaceuticals, Inc. is a public, American biopharmaceutical company focused on medical applications of a class of ion channel modulators called prostones. Sucampo has two marketed products, Amitiza and Rescula. Wikipedia

Employees:
140
Market Cap:
$441.62 million
Revenue:
$230 million
5 Year Trend:
33.2%
Net Income:
$18.49 million
NASDAQ:
SCMP